Literature DB >> 884391

The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.

M R Fennessy, D A Taylor.   

Abstract

1. Rats were injected intravenously with 2 mg/kg (-)-trans-delta9-tetrahydrocannabinol (delta9-THC) at ambient temperatures of 4 degrees, 21 degrees, 31 degrees and 37 degrees C. 2. The general behavior exhibited by rats treated with delta9-THC was similar at all four ambient temperatures. 3. Body temperatures were recorded continuously before and after drug administration. At 4 degrees and 21 degrees C, delta9-THC caused hypothermia whereas no change in body temperature occurred at 31 degrees and 37 degrees C. 4. The concentrations in the whole brain of noradrenaline (NA), dopamine, 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) were determined spectrophotofluorimetrically 1 h after drug administration. At 4 degrees C delta9-THC caused an increase of 5-HT, at 21 degrees C an increase of 5-HIAA, at 21 degrees C an increase of 5-HIAA AND A decrease of NA, and at 37 degrees C an increase of 5-HT and 5-HIAA. 5. At all ambient temperatures, delta9-THC increased the brain levels of 5-HT and/or 5-HIAA. A correlation between the delta9-THC-induced hypothermic response and the possible alteration of brain 5-HT metabolism cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884391      PMCID: PMC1667176          DOI: 10.1111/j.1476-5381.1977.tb16748.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Effect of psychotropic drugs on tryptophan concentration in the rat brain.

Authors:  A Tagliamonte; P Tagliamonte; J Perez-Cruet; S Stern; G L Gessa
Journal:  J Pharmacol Exp Ther       Date:  1971-06       Impact factor: 4.030

2.  Injectible dispersion of delta 9-tetrahydrocannabinol in saline using polyvinylpyrrolidone.

Authors:  D C Fenimore; P R Loy
Journal:  J Pharm Pharmacol       Date:  1971-04       Impact factor: 3.765

3.  The effects of chronic treatment with delta 9-tetrahydrocannabinol on catecholamine synthesis in the rat.

Authors:  I M Mazurkiewicz-Kwilecki; M Filczewski
Journal:  Psychopharmacologia       Date:  1973-10-23

4.  Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol.

Authors:  D W Gallager; E Sanders-Bush; F Sulser
Journal:  Psychopharmacologia       Date:  1972

Review 5.  The chemical estimation of catecholamines and their metabolites in body fluids and tissue extracts.

Authors:  H Weil-Malherbe
Journal:  Methods Biochem Anal       Date:  1971

6.  Simultaneous determination of indole- and catecholamines in tissues using a weak cation-exchange resin.

Authors:  J Barchas; E Erdelyi; P Angwin
Journal:  Anal Biochem       Date:  1972-11       Impact factor: 3.365

7.  A paradoxical effect for 1 -tetrahydrocannabinol on rectal temperature in rats.

Authors:  R D Sofia
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-09

8.  Evaluation of the hypothermic action of tetrahydrocannabinols in mice and squirrel monkeys.

Authors:  C O Haavik; H F Hardman
Journal:  J Pharmacol Exp Ther       Date:  1973-12       Impact factor: 4.030

Review 9.  General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.

Authors:  H F Hardman; E F Domino; M H Seevers
Journal:  Pharmacol Rev       Date:  1971-12       Impact factor: 25.468

10.  Effect of environmental temperature on the turnover of noradrenaline in hypothalamus and other areas of rat brain.

Authors:  M A Simmonds
Journal:  J Physiol       Date:  1969-07       Impact factor: 5.182

View more
  14 in total

1.  Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.

Authors:  Charles W Schindler; Benjamin R Gramling; Zuzana Justinova; Eric B Thorndike; Michael H Baumann
Journal:  Drug Alcohol Depend       Date:  2017-08-18       Impact factor: 4.492

Review 2.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

3.  Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Authors:  Erica Y Shen; Syed F Ali; Jerrold S Meyer
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

4.  delta 9-Tetrahydrocannabinol reduces brain regional histamine concentrations.

Authors:  M R Fennessy; S J Lewis; D A Taylor; A J Verberne
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

5.  Interaction of ambient temperature with the effects of delta 9-tetrahydrocannabinol on brain catecholamine synthesis and plasma corticosterone levels.

Authors:  A S Bloom; C J Kiernan
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.

Authors:  J A Davies; J D Graham
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.

Authors:  D A Taylor; M R Fennessy
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

8.  Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.

Authors:  M R Fennessy; D A Taylor
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

9.  Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.

Authors:  A J Verberne; D A Taylor; M R Fennessy
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Endogenous cannabinoids induce fever through the activation of CB1 receptors.

Authors:  D Fraga; C I S Zanoni; G A Rae; C A Parada; G E P Souza
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.